What is Axoden Plus Injection?

Axoden Plus Injection is a combination of Nicotinamide, Cynacobalamin, and Folic acid, used to treat or prevent vitamin deficiency, which can lead to anemia and nerve issues.

What is Vitamin deficiency anemia?

Vitamin deficiency anemia is a condition characterized by a lack of healthy red blood cells due to insufficient levels of certain vitamins, such as folic acid, vitamin B-12, and vitamin C. It can often be treated with vitamin supplements and dietary changes.

PlatinumRx

Axoden Plus Injection

Name: Axoden Plus Injection
Brand: Allites life Sciences Pvt. Ltd.
SKU: 1393207
Price: 115.00 INR
Availability: InStock

Salt Composition:

Vitamin B12 (Methylcobalamin) 500mcg + Vitamin B3 (Niacin) 100mg + Vitamin B6 (Pyridoxine) 100mg

Last updated on: 17-04-2025

Allites life Sciences Pvt. Ltd.

Vial of 1 ml

WHO GMP Certified

Long Expiry (>8 Months)

15 Days Easy Returns

General Information

Salt Composition

Vitamin B12 (Methylcobalamin) 500mcg + Vitamin B3 (Niacin) 100mg + Vitamin B6 (Pyridoxine) 100mg

Manufacturer

Allites life Sciences Pvt. Ltd.

Approved by

FDA

Doctor Approved & Trusted

Genuine Medicine

Pay On Delivery

Secure Payment

LegitScript Certified Online Pharmacy

Authentic & trustworthy information

Read out Editorial Policy

Having issues with the content?

Report Error

More About Axoden Plus Injection

Manufacturer Address

Plot No:1, Ground Floor, Jagath Avenue, 8th Cross Street Extension, New Colony, Chrompet, Chennai -600 044.

FAQ

Disclaimer

PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.

Authentic & trustworthy information

Read out Editorial Policy

Having issues with the content?

Report Error